glutathione nafld Novel Use for Oral Glutathione: Treatment of Nonalcoholic Fatty Liver Disease Ablating the glutaredoxin-2 (Glrx2) gene
Description
Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW
Monitor patients every two to four weeks after each dose reduction, with the option to pause or reverse a dose taper as needed
Annu Rev Entomol 67:105124
GST fusion protein aggregates interfere with reproducible proteinprotein interactions and thus undermine the reliability of the GST pulldown experiment
